PET/Imaging-Guided Piezo1-Mediated Mechanogenetic Memory Rescue with Low-Intensity Focused Ultrasound (LIFU): A Theoretical Model for Drug-Free Epigenetic BDNF Activation in Alzheimer's Disease

Current monoclonal antibodies used in Alzheimer's disease (AD) treatments struggle to cross the blood-brain barrier (BBB), an impenetrable wall protecting the brain [1, 2]. Because only a tiny fraction of drugs reaches the brain, high doses must be given, which overstimulates immune cells and can lead to deadly side effects called ARIA (brain edema and microbleeds) [3]. Instead of washing the brain with chemical agents or stressing the immune system, this paper presents a drug-free mechanogenetic model aiming to trigger the neurons' own genetic repair capacity through purely physical means. This innovative hypothesis relies on Low-Intensity Focused Ultrasound (LIFU) [4], applied under PET/MRI guidance, sent at the Theta frequency (4-8 Hz) that matches the brain's natural memory rhythm to precisely activate Piezo1 mechanosensors on neuron membranes [5]. The microscopic physical stress created by these drug-free sound waves initiates a calcium influx into the cell, allowing YAP/TAZ messenger proteins to migrate to the nucleus [6]. Reaching the nucleus, this mechanical signal stretches the DNA structure around the BDNF (repair) gene—which is locked and silenced by Alzheimer's pathology—and wakes it up. Aimed to be validated with 3D organoids in the lab, this platform could offer a new, safe treatment strategy that completely frees patients from chemical toxicity and ARIA risks, starting cellular repair directly from the nucleus.